Needham Downgrades Tscan Therapeutics Inc (TCRX) to Hold

September 2, 2026 1:49 PM EDT Send to a Friend
Needham analyst Gil Blum downgraded Tscan Therapeutics Inc (NASDAQ: TCRX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login